We are now on Biocrsyt radar. It is easier, faster and their success more certain if they were to successfully take-over Biota.
That would be a battle worth watching with 2 major holders. Other big pharma may also enter the fray.
The whole thing could even mean Biocryst cash depletion could make them a target.
Probably a very bad time to sell BTA under $3.
biota wins a us patent for treatment of cancer, page-4
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)